AT84713T - Use of calcium antagonists for customized edition of compositions for deprivation symptoms. - Google Patents

Use of calcium antagonists for customized edition of compositions for deprivation symptoms.

Info

Publication number
AT84713T
AT84713T AT86106111T AT86106111T AT84713T AT 84713 T AT84713 T AT 84713T AT 86106111 T AT86106111 T AT 86106111T AT 86106111 T AT86106111 T AT 86106111T AT 84713 T AT84713 T AT 84713T
Authority
AT
Austria
Prior art keywords
customized
edition
compositions
use
calcium antagonists
Prior art date
Application number
AT86106111T
Other languages
German (de)
Inventor
Esam E El-Fakahany
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US73366485A priority Critical
Application filed by Miles Inc filed Critical Miles Inc
Priority to EP86106111A priority patent/EP0204951B1/en
Publication of AT84713T publication Critical patent/AT84713T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/81Addiction
    • Y10S514/812Narcotic
AT86106111T 1985-05-13 1986-05-05 Use of calcium antagonists for customized edition of compositions for deprivation symptoms. AT84713T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US73366485A true 1985-05-13 1985-05-13
EP86106111A EP0204951B1 (en) 1985-05-13 1986-05-05 Use of calcium channel blockers in the production of compositions for withdrawal symptoms

Publications (1)

Publication Number Publication Date
AT84713T true AT84713T (en) 1993-02-15

Family

ID=24948609

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86106111T AT84713T (en) 1985-05-13 1986-05-05 Use of calcium antagonists for customized edition of compositions for deprivation symptoms.

Country Status (6)

Country Link
US (1) US4797410A (en)
EP (1) EP0204951B1 (en)
JP (1) JPH0584287B2 (en)
AT (1) AT84713T (en)
CA (1) CA1275928C (en)
DE (2) DE3687541D1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806277A1 (en) * 1988-02-27 1989-09-07 Troponwerke Gmbh & Co Kg derivatives of 1,4-dihydropyridine-use of
KR0169115B1 (en) * 1989-03-22 1999-01-15 케이 티 팡 피터 Parathyroid hypertensive factor
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
CA2016465A1 (en) * 1989-06-02 1990-12-02 Zola Phillip Horovitz Method for preventing or treating anxiety employing a calcium channel blocker
US5124340A (en) * 1989-06-28 1992-06-23 The United States Of America As Represented By The Department Of Health And Human Services Use of calcium channel blocker to prevent cocaine induced craving and reinforcement
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
IL109460A (en) 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
GB9519363D0 (en) 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
CN100475210C (en) * 1996-03-08 2009-04-08 尼科梅德丹麦有限公司 Modified release multiple-units dosage composition
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2305218A1 (en) 1999-10-29 2011-04-06 Euro-Celtique S.A. Controlled release hydrocodone formulations
GB0019055D0 (en) * 2000-08-03 2000-09-27 Unilever Plc Antiperspirant and deodorant products and methods for their use
KR101167465B1 (en) 2000-10-30 2012-07-27 유로-셀티크 소시에떼 아노뉨 Controlled release hydrocodone formulations
ES2523145T3 (en) * 2001-05-02 2014-11-21 Euro-Celtique S.A. Oxycodone formulations to be administered once a day
WO2008011595A2 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophobic abuse deterrent delivery system
US20170071879A1 (en) * 2015-09-15 2017-03-16 Alexandre Vamvakides Prototypical analgesic profile of 3,3-diphenyl-n-(1-phenylethyl)propan-1-amine (fendiline)
GR1009145B (en) * 2016-08-10 2017-10-20 Αλεξανδροσ Δημητριου Βαμβακιδησ Prototypical analgetic activity of the fendiline

Also Published As

Publication number Publication date
US4797410A (en) 1989-01-10
DE3687541D1 (en) 1993-03-04
EP0204951B1 (en) 1993-01-20
JPS61260025A (en) 1986-11-18
JPH0584287B2 (en) 1993-12-01
DE3687541T2 (en) 1993-05-13
EP0204951A2 (en) 1986-12-17
CA1275928C (en) 1990-11-06
EP0204951A3 (en) 1990-05-30

Similar Documents

Publication Publication Date Title
DE3869192D1 (en) Additives for cement.
DE3772474D1 (en) Device for monitoring of flugzeugkabinenlaerm.
DE3679585D1 (en) System for the settlement of transactions.
DE3875758D1 (en) Geraet for observation of blutstroemung.
DE3786558D1 (en) Composition for the treatment of obesity.
DE3779807D1 (en) Sensor element for determination of compound concentrations.
DE3504580A1 (en) Water-containing composition for oral use
AT122231T (en) Use of opium antagonists for the manufacture of a pharmaceutical composition for treatment of alcoholism.
DE3768900D1 (en) Sensor element for determination of compound concentrations.
MX163348A (en) Surgical fastener made of polymer mixture
DE3671263D1 (en) Set of structural elements for construction of buildings.
DE3382156D1 (en) Use of 8-substituted-containing guanosinderivaten compositions for the preparation of medicaments.
IT1199838B (en) Methods for the preparation of dressings
DE3680876D1 (en) Geraet to zahnaerztlichen observation.
DE3543042A1 (en) Orthopedic device for the axial external fixation
DE3381877D1 (en) Use of opium antagonist for the manufacture of medicines to correct gastrointestinal disorders.
DE3781067D1 (en) uebertragungsaufzeichnungsverfahren Uebertragungsaufzeichnungsmittel and their use for.
DE3686645D1 (en) Pharmaceutical compositions for improving wound healing.
MX163228B (en) low lubricant composition or phosphorus-free
ES529091A0 (en) Procedure for obtaining lipopeptides
DE3584270D1 (en) Prosthesis for connective tissue.
DE69132352D1 (en) Protein antagonists of the blood-coagulation and their use
ES2025066B3 (en) stable composition for the determination of peroxidatively active substances.
FR2584603B1 (en) Prothese of the improved hip
DE3610844A1 (en) Dental cement mass

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee